Dveus Designs Group

The transition from two-dimensional scans to three-dimensional visualizations represents a monumental shift in medical diagnostics. Holographic imaging provides a depth of field and spatial awareness that traditional MRI or CT slices simply cannot match. By projecting light to create a free-floating, three-dimensional representation of an organ or anatomical structure, surgeons can "walk through" a patient’s heart or brain before ever making an incision.

One of the primary advantages of this technology is the reduction of cognitive load on the physician. Currently, doctors must mentally reconstruct 2D images into a 3D model. Holography does this work for them, allowing for more precise surgical planning and improved patient education. When a patient can see their own pathology in a tangible, spatial format, their understanding of the procedure and subsequent compliance often increases.

However, the integration of holography into standard practice faces hurdles regarding data processing speeds and hardware ergonomics. For real-time use…

The artificial pancreas implant represents a major leap in diabetes management, moving away from external pumps toward a fully internalized, closed-loop system. This device mimics the biological function of a healthy pancreas by continuously monitoring blood glucose levels and automatically delivering the precise amount of insulin needed to maintain stability.

The system consists of three main components: a continuous glucose monitor (CGM), an insulin reservoir and pump, and a sophisticated control algorithm. The algorithm processes real-time data from the sensor and adjusts insulin delivery every few minutes, effectively eliminating the need for finger-prick testing and manual injections.

Internalized implants offer the advantage of discreetness and improved quality of life, as patients no longer need to carry external equipment. The challenge remains the longevity of the glucose sensor and the refill mechanism for the insulin reservoir. Current research is focusing on peritoneal delivery, which more closely mirrors the natural route of…

Renal disease is characterized by the progressive loss of kidney function, leading to systemic imbalances in fluid, electrolytes, and metabolic waste. Management in 2026 focuses on early detection through novel protein markers and the implementation of therapies that specifically target the inflammatory and fibrotic pathways responsible for nephron degradation.

Early intervention is the most effective way to slow the progression of chronic kidney disease (CKD) toward end-stage failure. While traditional markers like serum creatinine remain in use, modern protocols increasingly incorporate tests for tubular damage, which can signal structural changes in the kidney long before filtration rates significantly decline.

The current standard of care for renal preservation involves what is frequently referred to as the "four pillars" of therapy. This includes the use of SGLT2 inhibitors, which reduce intra-glomerular pressure; renin-angiotensin system (RAS) blockade to control blood pressure and proteinuria; mineralocorticoid receptor antagonists to limit fibrosis; and GLP-1 receptor agonists…

Welcome to our group Dveus Designs Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.